Marco Volante

19.1k total citations · 1 hit paper
320 papers, 12.4k citations indexed

About

Marco Volante is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Marco Volante has authored 320 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Oncology, 96 papers in Surgery and 91 papers in Epidemiology. Recurrent topics in Marco Volante's work include Neuroendocrine Tumor Research Advances (85 papers), Adrenal and Paraganglionic Tumors (57 papers) and Neuroblastoma Research and Treatments (57 papers). Marco Volante is often cited by papers focused on Neuroendocrine Tumor Research Advances (85 papers), Adrenal and Paraganglionic Tumors (57 papers) and Neuroblastoma Research and Treatments (57 papers). Marco Volante collaborates with scholars based in Italy, United States and Germany. Marco Volante's co-authors include Mauro Papotti, Ida Rapa, Giorgio V. Scagliotti, Gianni Bussolati, Luisella Righi, Massimo Terzolo, Silvia Novello, Elena Allìa, Paolo Ceppi and Ezio Ghigo and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marco Volante

315 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

2022 150 citations Marco Volante, Mauro Papotti et al. Endocrine Pathology profile →

Peers

Countries citing papers authored by Marco Volante

Since Specialization

Citations

This map shows the geographic impact of Marco Volante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Volante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Volante more than expected).

Fields of papers citing papers by Marco Volante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Volante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Volante. The network helps show where Marco Volante may publish in the future.

Co-authorship network of co-authors of Marco Volante

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Volante. A scholar is included among the top collaborators of Marco Volante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Volante. Marco Volante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non–Small-Cell Lung Cancer 2025 ·Journal of Molecular Diagnostics ·Ida Rapa, Francesca Bertola, Gaia Roversi, (unknown), Federica Panebianco, Cecília Durães, Enzo Gallo, Biagio Eugenio Leone, (unknown), Luisella Righi, Paolo Visca, Marco Volante, Simonetta Buglioni	0
2	Changes in categorization or nomenclature within neuroendocrine tumors 2024 ·Endocrine Related Cancer ·(unknown), Marco Volante	2
3	Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal origin 2023 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Paolo Graziano, Paola Parente, (unknown), Massimo Milione, Giovanni Centonze, Marco Volante, Alberto Cavazza, (unknown), Giuseppe Maggio, Teresa Balsamo, (unknown), Giulio Rossi, Antônio Rossi, Lucia Anna Muscarella	2
4	Heterogeneity of TPIT expression in ACTH-secreting extra-pituitary neuroendocrine tumors (NETs) supports the existence of different cellular programs in pancreatic and pulmonary NETs 2023 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Silvia Uccella, (unknown), (unknown), Roberta Maragliano, (unknown), (unknown), Maria Laura Tanda, Marco Volante, Dario Diviani, Stefano La Rosa	3
5	European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for appendiceal neuroendocrine tumours ( aNET ) 2023 ·Journal of Neuroendocrinology ·Gregory Kaltsas, Thomas Walter, Ulrich Knigge, Christos Toumpanakis, Ana Paula Santos, Nehara Begum, Ulrich F. Pape, Marco Volante, Andrea Frilling, Anne Couvelard	19
6	The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 2023 ·European Journal of Endocrinology ·Anna Calabrese, Soraya Puglisi, (unknown), Vittoria Basile, Paola Perotti, Anna Pia, Paola Berchialla, Marco Volante, Cristian Fiori, F. Porpiglia, Andrea Veltri, Giuseppe Reimondo, Massimo Terzolo	7
7	Updates on lung neuroendocrine neoplasm classification 2023 ·Histopathology ·(unknown), Luisella Righi, Marco Volante, Mauro Papotti	13
8	Clinical and Pathological Features and Gene Expression Profiles of Clinically Aggressive Papillary Thyroid Carcinomas 2023 ·Endocrine Pathology ·Jasna Metović, (unknown), Simona Osella‐Abate, Giulia Orlando, (unknown), Francesca Napoli, Francesca Maletta, Lorenzo Daniele, Marco Volante, Mauro Papotti	7
9	The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports 2023 ·Endocrine Pathology ·Shereen Ezzat, Wouter W. de Herder, Marco Volante, Ashley Grossman	3
10	Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors 2022 ·Endocrine Pathology ·Jasna Metović, Anna La Salvia, Ida Rapa, Francesca Napoli, Nadia Birocco, (unknown), Rocio García‐Carbonero, Libero Ciuffreda, Giorgio V. Scagliotti, Mauro Papotti, Marco Volante	17
11	Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review 2022 ·Seminars in Oncology ·(unknown), (unknown), Anna La Salvia, (unknown), Marco Volante, Consuelo Buttigliero, Giorgio V. Scagliotti, Maria Pia Brizzi	1
12	Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma 2021 ·Cancers ·Francesca Napoli, Angela Listì, Vanessa Zambelli, (unknown), Paolo Bironzo, Mauro Papotti, Marco Volante, Giorgio V. Scagliotti, Luisella Righi	16
13	Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation 2020 ·European Radiology ·Andrea Veltri, (unknown), Marco Calandri, (unknown), Marco Volante, F. Porpiglia, Anna Calabrese, Soraya Puglisi, Vittoria Basile, Massimo Terzolo	15
14	Outcome and diagnostic reproducibility of the thyroid cytology “indeterminate categories” SIAPEC/SIE 2014 in a consecutive series of 302 cases 2020 ·Journal of Endocrinological Investigation ·Federica Massa, P. Caraci, Anna Sapino, Gaetano De Rosa, Marco Volante, Mauro Papotti	7
15	Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Isabel Weigand, Barbara Altieri, (unknown), Vittoria Basile, Stefan Kircher, Laura‐Sophie Landwehr, Jochen Schreiner, Maria Cláudia Nogueira Zerbini, Cristina L. Ronchi, Felix Megerle, Alfredo Berruti, Letizia Canu, Marco Volante, Isabel Paiva, Silvia Della Casa, Silviu Sbiera, Martin Faßnacht, Maria Candida Barisson Villares Fragoso, Massimo Terzolo, Matthias Kroiß	21
16	The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Jasna Metović, (unknown), Laura Annaratone, Simona Osella‐Abate, Francesca Maletta, Ida Rapa, (unknown), S Patriarca, Marco Gallo, Yuri E. Nikiforov, Marco Volante, Mauro Papotti	10
17	CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids 2013 ·Clinical Cancer Research ·Dorian R.A. Swarts, Mieke E.R. Henfling, Leander Van Neste, Robert‐Jan van Suylen, Anne‐Marie C. Dingemans, Winand N.M. Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante, Wim Van Criekinge, Manon van Engeland, Frans C.�S. Ramaekers, Ernst‐Jan M. Speel	67
18	Ribonucleotide Reductase Large Subunit ( RRM1 ) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer 2012 ·Clinical Cancer Research ·Marco Volante, Massimo Terzolo, Martin Faßnacht, Ida Rapa, Antonina Germano, Silviu Sbiera, Fulvia Daffara, Paola Sperone, Giorgio V. Scagliotti, Bruno Allolio, Mauro Papotti, Alfredo Berruti	52
19	Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin 2009 ·Molecular Cancer Therapeutics ·Paolo Ceppi, Mauro Papotti, Valentina Monica, Marco Lo Iacono, Silvia Saviozzi, Marisa Pautasso, Silvia Novello, (unknown), Enrico Bracco, Marco Volante, Giorgio V. Scagliotti	51
20	Non–Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways 2009 ·Cancer Research ·Silvia Saviozzi, Paolo Ceppi, Silvia Novello, (unknown), Marco Lo Iacono, P. Borasio, Alberto Cambieri, Marco Volante, Mauro Papotti, Raffaele Calogero, Giorgio V. Scagliotti	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact